EUVIMEDEUVIMED entdecken
Open Access

Biologic Versus Synthetic Mesh in Ventral Hernia Repair: Participant-Level Analysis of Two Randomized Controlled Trials at Twenty-Four to Thirty-Six Months

Naila H Dhanani, Kyung Hyun Lee, Oscar A Olavarria, Charlotte Young, Frank Primus, Julie L Holihan, Mike K Liang, Hobart W Harris

Surgical Infections · 01.08.2023 · 24 (6) · 554-560

DOI: 10.1089/sur.2022.342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgical Infections, erschienen am 01.08.2023. Verfasst von Naila H Dhanani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Lyndon B. Johnson Hospital, McGovern Medical School at UTHealth, Houston, Texas, USA. Hauptthemen laut MEDLINE: Hernia, Ventral, Biological Products. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biologic mesh has been used increasingly in complex ventral hernia repair despite limited evidence at low risk of bias supporting its use. Patients and Methods: We performed a participant-level analysis of published randomized controlled trials (RCTs) comparing biologic to synthetic mesh with complex ventral hernia repair at 24 to 36 months. Primary outcome was major complication (composite of mesh infection, recurrence, reoperation, or death) at 24 to 36 months post-operative. Secondary outcomes included length of index hospital stay, surgical site occurrence, surgical site infection, and death. Outcomes were assessed using both frequentist and Bayesian generalized linear regression models.

Results

A total of 252 patients from two RCTs were included, 126 patients randomized to the intervention arm of biologic and 126 patients to the control of synthetic mesh with median follow-up of 29 (23, 38) months. Major complication occurred in 33 (33%) patients randomized to biologic, and 39 (38%) patients randomized to synthetic mesh, (relative risk [RR] 0.91, 95% confidence interval [CI] 0.63-1.31; p value = 0.600). Bayesian analysis demonstrated that compared with synthetic mesh, biologic mesh had similar probability of major complications at 24 to 36 months post-operative. The remainder of outcomes demonstrated slight benefit with synthetic mesh as opposed to biologic mesh except for mesh infection. However, under a frequentist framework, no outcome was statistically different.

Conclusions

In patients undergoing open ventral hernia repair, there was no benefit for patients receiving biologic versus synthetic mesh at 24 to 36 months post-operative.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hernia, VentralBiological ProductsHumansSurgical MeshRandomized Controlled Trials as TopicSurgical Wound InfectionHerniorrhaphyTreatment OutcomeRecurrenceRetrospective Studies

Stichwörter der Autor:innen

biologic meshsynthetic meshventral hernia

Substanzen

Biological Products

Autor:innen und Institutionen

  • Department of Surgery, Lyndon B. Johnson Hospital, McGovern Medical School at UTHealth, Houston, Texas, USA.
  • Center of Clinical Research and Evidence-Based Medicine, McGovern Medical School at UTHealth, Houston, Texas, USA.
  • Department of Surgery, University of California at San Francisco, San Francisco, California, USA.
  • Department of Surgery, HCA Healthcare Kingwood, University of Houston, Kingwood, Texas, USA.

Förderung

  • NCATS NIH HHS

Zitieren

APA

Dhanani, N. H., Lee, K. H., Olavarria, O. A., Young, C., Primus, F., Holihan, J. L., Liang, M. K., & Harris, H. W. (2023). Biologic Versus Synthetic Mesh in Ventral Hernia Repair: Participant-Level Analysis of Two Randomized Controlled Trials at Twenty-Four to Thirty-Six Months. Surgical Infections, 24(6), 554-560. https://doi.org/10.1089/sur.2022.342

Vancouver

Dhanani NH, Lee KH, Olavarria OA, Young C, Primus F, Holihan JL, et al. Biologic Versus Synthetic Mesh in Ventral Hernia Repair: Participant-Level Analysis of Two Randomized Controlled Trials at Twenty-Four to Thirty-Six Months. Surgical Infections. 2023;24(6):554-560. doi:10.1089/sur.2022.342

BibTeX
@article{Dhanani2023,
  author = {Dhanani, Naila H and Lee, Kyung Hyun and Olavarria, Oscar A and Young, Charlotte and Primus, Frank and Holihan, Julie L and Liang, Mike K and Harris, Hobart W},
  title = {Biologic Versus Synthetic Mesh in Ventral Hernia Repair: Participant-Level Analysis of Two Randomized Controlled Trials at Twenty-Four to Thirty-Six Months},
  journal = {Surgical Infections},
  year = {2023},
  volume = {24},
  number = {6},
  pages = {554--560},
  doi = {10.1089/sur.2022.342}
}
Kostenlos starten →